Reinsurance as a tool to mitigate risk in an alternative payment model

  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
By Robert D. Bachler, Nicholas Johnson, Meredith Russell, Pamela M. Pelizzari | 24 April 2019

Oncology alternative payment model (APM) concepts have been growing in popularity in recent years. Several factors are driving this popularity, including the high cost of treating oncology patients as well as the desire to better align incentives across stakeholders and encourage value for patients and purchasers. This report discusses the impact of various types of reinsurance on the risk posed to provider groups by oncology APMs similar in structure to the Oncology Care Model.

This report was commissioned by Amgen.